Global Non-invasive Parenteral Screening Instruments Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Non-invasive Parenteral Screening Instruments market size was valued at US$ 3729.1 million in 2023. With growing demand in downstream market, the Non-invasive Parenteral Screening Instruments is forecast to a readjusted size of US$ 7247.9 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global Non-invasive Parenteral Screening Instruments market. Non-invasive Parenteral Screening Instruments are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-invasive Parenteral Screening Instruments. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-invasive Parenteral Screening Instruments market.
Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Non-invasive Parenteral Screening Instruments market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-invasive Parenteral Screening Instruments market. It may include historical data, market segmentation by Type (e.g., Ultrasound Devices, Next-Generation Sequencing Systems), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-invasive Parenteral Screening Instruments market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-invasive Parenteral Screening Instruments market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-invasive Parenteral Screening Instruments industry. This include advancements in Non-invasive Parenteral Screening Instruments technology, Non-invasive Parenteral Screening Instruments new entrants, Non-invasive Parenteral Screening Instruments new investment, and other innovations that are shaping the future of Non-invasive Parenteral Screening Instruments.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-invasive Parenteral Screening Instruments market. It includes factors influencing customer ' purchasing decisions, preferences for Non-invasive Parenteral Screening Instruments product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-invasive Parenteral Screening Instruments market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-invasive Parenteral Screening Instruments market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-invasive Parenteral Screening Instruments market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-invasive Parenteral Screening Instruments industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-invasive Parenteral Screening Instruments market.
Market Segmentation:
Non-invasive Parenteral Screening Instruments market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Non-invasive Parenteral Screening Instruments market size was valued at US$ 3729.1 million in 2023. With growing demand in downstream market, the Non-invasive Parenteral Screening Instruments is forecast to a readjusted size of US$ 7247.9 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global Non-invasive Parenteral Screening Instruments market. Non-invasive Parenteral Screening Instruments are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-invasive Parenteral Screening Instruments. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-invasive Parenteral Screening Instruments market.
Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Non-invasive Parenteral Screening Instruments market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-invasive Parenteral Screening Instruments market. It may include historical data, market segmentation by Type (e.g., Ultrasound Devices, Next-Generation Sequencing Systems), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-invasive Parenteral Screening Instruments market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-invasive Parenteral Screening Instruments market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-invasive Parenteral Screening Instruments industry. This include advancements in Non-invasive Parenteral Screening Instruments technology, Non-invasive Parenteral Screening Instruments new entrants, Non-invasive Parenteral Screening Instruments new investment, and other innovations that are shaping the future of Non-invasive Parenteral Screening Instruments.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-invasive Parenteral Screening Instruments market. It includes factors influencing customer ' purchasing decisions, preferences for Non-invasive Parenteral Screening Instruments product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-invasive Parenteral Screening Instruments market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-invasive Parenteral Screening Instruments market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-invasive Parenteral Screening Instruments market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-invasive Parenteral Screening Instruments industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-invasive Parenteral Screening Instruments market.
Market Segmentation:
Non-invasive Parenteral Screening Instruments market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Ultrasound Devices
- Next-Generation Sequencing Systems
- Polymerase Chain Reaction Instruments
- Microarrays
- Others
- Diagnostic Laboratories
- Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE Healthcare
- Philips
- Illumina
- Thermo Fisher Scientific
- Roche
- PacBio
- Perkinelmer
- Qiagen
- Agilent Technologies
- BGI Group
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Parenteral Screening Instruments Market Size 2019-2030
2.1.2 Non-invasive Parenteral Screening Instruments Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Non-invasive Parenteral Screening Instruments Segment by Type
2.2.1 Ultrasound Devices
2.2.2 Next-Generation Sequencing Systems
2.2.3 Polymerase Chain Reaction Instruments
2.2.4 Microarrays
2.2.5 Others
2.3 Non-invasive Parenteral Screening Instruments Market Size by Type
2.3.1 Non-invasive Parenteral Screening Instruments Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
2.4 Non-invasive Parenteral Screening Instruments Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals
2.5 Non-invasive Parenteral Screening Instruments Market Size by Application
2.5.1 Non-invasive Parenteral Screening Instruments Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
3 NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS MARKET SIZE BY PLAYER
3.1 Non-invasive Parenteral Screening Instruments Market Size Market Share by Players
3.1.1 Global Non-invasive Parenteral Screening Instruments Revenue by Players (2019-2024)
3.1.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Players (2019-2024)
3.2 Global Non-invasive Parenteral Screening Instruments Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS BY REGIONS
4.1 Non-invasive Parenteral Screening Instruments Market Size by Regions (2019-2024)
4.2 Americas Non-invasive Parenteral Screening Instruments Market Size Growth (2019-2024)
4.3 APAC Non-invasive Parenteral Screening Instruments Market Size Growth (2019-2024)
4.4 Europe Non-invasive Parenteral Screening Instruments Market Size Growth (2019-2024)
4.5 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)
5.2 Americas Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
5.3 Americas Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024)
6.2 APAC Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
6.3 APAC Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-invasive Parenteral Screening Instruments by Country (2019-2024)
7.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
7.3 Europe Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Parenteral Screening Instruments by Region (2019-2024)
8.2 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
8.3 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS MARKET FORECAST
10.1 Global Non-invasive Parenteral Screening Instruments Forecast by Regions (2025-2030)
10.1.1 Global Non-invasive Parenteral Screening Instruments Forecast by Regions (2025-2030)
10.1.2 Americas Non-invasive Parenteral Screening Instruments Forecast
10.1.3 APAC Non-invasive Parenteral Screening Instruments Forecast
10.1.4 Europe Non-invasive Parenteral Screening Instruments Forecast
10.1.5 Middle East & Africa Non-invasive Parenteral Screening Instruments Forecast
10.2 Americas Non-invasive Parenteral Screening Instruments Forecast by Country (2025-2030)
10.2.1 United States Non-invasive Parenteral Screening Instruments Market Forecast
10.2.2 Canada Non-invasive Parenteral Screening Instruments Market Forecast
10.2.3 Mexico Non-invasive Parenteral Screening Instruments Market Forecast
10.2.4 Brazil Non-invasive Parenteral Screening Instruments Market Forecast
10.3 APAC Non-invasive Parenteral Screening Instruments Forecast by Region (2025-2030)
10.3.1 China Non-invasive Parenteral Screening Instruments Market Forecast
10.3.2 Japan Non-invasive Parenteral Screening Instruments Market Forecast
10.3.3 Korea Non-invasive Parenteral Screening Instruments Market Forecast
10.3.4 Southeast Asia Non-invasive Parenteral Screening Instruments Market Forecast
10.3.5 India Non-invasive Parenteral Screening Instruments Market Forecast
10.3.6 Australia Non-invasive Parenteral Screening Instruments Market Forecast
10.4 Europe Non-invasive Parenteral Screening Instruments Forecast by Country (2025-2030)
10.4.1 Germany Non-invasive Parenteral Screening Instruments Market Forecast
10.4.2 France Non-invasive Parenteral Screening Instruments Market Forecast
10.4.3 UK Non-invasive Parenteral Screening Instruments Market Forecast
10.4.4 Italy Non-invasive Parenteral Screening Instruments Market Forecast
10.4.5 Russia Non-invasive Parenteral Screening Instruments Market Forecast
10.5 Middle East & Africa Non-invasive Parenteral Screening Instruments Forecast by Region (2025-2030)
10.5.1 Egypt Non-invasive Parenteral Screening Instruments Market Forecast
10.5.2 South Africa Non-invasive Parenteral Screening Instruments Market Forecast
10.5.3 Israel Non-invasive Parenteral Screening Instruments Market Forecast
10.5.4 Turkey Non-invasive Parenteral Screening Instruments Market Forecast
10.5.5 GCC Countries Non-invasive Parenteral Screening Instruments Market Forecast
10.6 Global Non-invasive Parenteral Screening Instruments Forecast by Type (2025-2030)
10.7 Global Non-invasive Parenteral Screening Instruments Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare Non-invasive Parenteral Screening Instruments Product Offered
11.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GE Healthcare Main Business Overview
11.1.5 GE Healthcare Latest Developments
11.2 Philips
11.2.1 Philips Company Information
11.2.2 Philips Non-invasive Parenteral Screening Instruments Product Offered
11.2.3 Philips Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Philips Main Business Overview
11.2.5 Philips Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Non-invasive Parenteral Screening Instruments Product Offered
11.3.3 Illumina Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product Offered
11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Non-invasive Parenteral Screening Instruments Product Offered
11.5.3 Roche Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 PacBio
11.6.1 PacBio Company Information
11.6.2 PacBio Non-invasive Parenteral Screening Instruments Product Offered
11.6.3 PacBio Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 PacBio Main Business Overview
11.6.5 PacBio Latest Developments
11.7 Perkinelmer
11.7.1 Perkinelmer Company Information
11.7.2 Perkinelmer Non-invasive Parenteral Screening Instruments Product Offered
11.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Perkinelmer Main Business Overview
11.7.5 Perkinelmer Latest Developments
11.8 Qiagen
11.8.1 Qiagen Company Information
11.8.2 Qiagen Non-invasive Parenteral Screening Instruments Product Offered
11.8.3 Qiagen Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Qiagen Main Business Overview
11.8.5 Qiagen Latest Developments
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Information
11.9.2 Agilent Technologies Non-invasive Parenteral Screening Instruments Product Offered
11.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Agilent Technologies Main Business Overview
11.9.5 Agilent Technologies Latest Developments
11.10 BGI Group
11.10.1 BGI Group Company Information
11.10.2 BGI Group Non-invasive Parenteral Screening Instruments Product Offered
11.10.3 BGI Group Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BGI Group Main Business Overview
11.10.5 BGI Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive Parenteral Screening Instruments Market Size 2019-2030
2.1.2 Non-invasive Parenteral Screening Instruments Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Non-invasive Parenteral Screening Instruments Segment by Type
2.2.1 Ultrasound Devices
2.2.2 Next-Generation Sequencing Systems
2.2.3 Polymerase Chain Reaction Instruments
2.2.4 Microarrays
2.2.5 Others
2.3 Non-invasive Parenteral Screening Instruments Market Size by Type
2.3.1 Non-invasive Parenteral Screening Instruments Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
2.4 Non-invasive Parenteral Screening Instruments Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals
2.5 Non-invasive Parenteral Screening Instruments Market Size by Application
2.5.1 Non-invasive Parenteral Screening Instruments Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
3 NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS MARKET SIZE BY PLAYER
3.1 Non-invasive Parenteral Screening Instruments Market Size Market Share by Players
3.1.1 Global Non-invasive Parenteral Screening Instruments Revenue by Players (2019-2024)
3.1.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Players (2019-2024)
3.2 Global Non-invasive Parenteral Screening Instruments Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS BY REGIONS
4.1 Non-invasive Parenteral Screening Instruments Market Size by Regions (2019-2024)
4.2 Americas Non-invasive Parenteral Screening Instruments Market Size Growth (2019-2024)
4.3 APAC Non-invasive Parenteral Screening Instruments Market Size Growth (2019-2024)
4.4 Europe Non-invasive Parenteral Screening Instruments Market Size Growth (2019-2024)
4.5 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)
5.2 Americas Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
5.3 Americas Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024)
6.2 APAC Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
6.3 APAC Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-invasive Parenteral Screening Instruments by Country (2019-2024)
7.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
7.3 Europe Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive Parenteral Screening Instruments by Region (2019-2024)
8.2 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
8.3 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS MARKET FORECAST
10.1 Global Non-invasive Parenteral Screening Instruments Forecast by Regions (2025-2030)
10.1.1 Global Non-invasive Parenteral Screening Instruments Forecast by Regions (2025-2030)
10.1.2 Americas Non-invasive Parenteral Screening Instruments Forecast
10.1.3 APAC Non-invasive Parenteral Screening Instruments Forecast
10.1.4 Europe Non-invasive Parenteral Screening Instruments Forecast
10.1.5 Middle East & Africa Non-invasive Parenteral Screening Instruments Forecast
10.2 Americas Non-invasive Parenteral Screening Instruments Forecast by Country (2025-2030)
10.2.1 United States Non-invasive Parenteral Screening Instruments Market Forecast
10.2.2 Canada Non-invasive Parenteral Screening Instruments Market Forecast
10.2.3 Mexico Non-invasive Parenteral Screening Instruments Market Forecast
10.2.4 Brazil Non-invasive Parenteral Screening Instruments Market Forecast
10.3 APAC Non-invasive Parenteral Screening Instruments Forecast by Region (2025-2030)
10.3.1 China Non-invasive Parenteral Screening Instruments Market Forecast
10.3.2 Japan Non-invasive Parenteral Screening Instruments Market Forecast
10.3.3 Korea Non-invasive Parenteral Screening Instruments Market Forecast
10.3.4 Southeast Asia Non-invasive Parenteral Screening Instruments Market Forecast
10.3.5 India Non-invasive Parenteral Screening Instruments Market Forecast
10.3.6 Australia Non-invasive Parenteral Screening Instruments Market Forecast
10.4 Europe Non-invasive Parenteral Screening Instruments Forecast by Country (2025-2030)
10.4.1 Germany Non-invasive Parenteral Screening Instruments Market Forecast
10.4.2 France Non-invasive Parenteral Screening Instruments Market Forecast
10.4.3 UK Non-invasive Parenteral Screening Instruments Market Forecast
10.4.4 Italy Non-invasive Parenteral Screening Instruments Market Forecast
10.4.5 Russia Non-invasive Parenteral Screening Instruments Market Forecast
10.5 Middle East & Africa Non-invasive Parenteral Screening Instruments Forecast by Region (2025-2030)
10.5.1 Egypt Non-invasive Parenteral Screening Instruments Market Forecast
10.5.2 South Africa Non-invasive Parenteral Screening Instruments Market Forecast
10.5.3 Israel Non-invasive Parenteral Screening Instruments Market Forecast
10.5.4 Turkey Non-invasive Parenteral Screening Instruments Market Forecast
10.5.5 GCC Countries Non-invasive Parenteral Screening Instruments Market Forecast
10.6 Global Non-invasive Parenteral Screening Instruments Forecast by Type (2025-2030)
10.7 Global Non-invasive Parenteral Screening Instruments Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare Non-invasive Parenteral Screening Instruments Product Offered
11.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GE Healthcare Main Business Overview
11.1.5 GE Healthcare Latest Developments
11.2 Philips
11.2.1 Philips Company Information
11.2.2 Philips Non-invasive Parenteral Screening Instruments Product Offered
11.2.3 Philips Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Philips Main Business Overview
11.2.5 Philips Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Non-invasive Parenteral Screening Instruments Product Offered
11.3.3 Illumina Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product Offered
11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Non-invasive Parenteral Screening Instruments Product Offered
11.5.3 Roche Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 PacBio
11.6.1 PacBio Company Information
11.6.2 PacBio Non-invasive Parenteral Screening Instruments Product Offered
11.6.3 PacBio Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 PacBio Main Business Overview
11.6.5 PacBio Latest Developments
11.7 Perkinelmer
11.7.1 Perkinelmer Company Information
11.7.2 Perkinelmer Non-invasive Parenteral Screening Instruments Product Offered
11.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Perkinelmer Main Business Overview
11.7.5 Perkinelmer Latest Developments
11.8 Qiagen
11.8.1 Qiagen Company Information
11.8.2 Qiagen Non-invasive Parenteral Screening Instruments Product Offered
11.8.3 Qiagen Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Qiagen Main Business Overview
11.8.5 Qiagen Latest Developments
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Information
11.9.2 Agilent Technologies Non-invasive Parenteral Screening Instruments Product Offered
11.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Agilent Technologies Main Business Overview
11.9.5 Agilent Technologies Latest Developments
11.10 BGI Group
11.10.1 BGI Group Company Information
11.10.2 BGI Group Non-invasive Parenteral Screening Instruments Product Offered
11.10.3 BGI Group Non-invasive Parenteral Screening Instruments Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BGI Group Main Business Overview
11.10.5 BGI Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-invasive Parenteral Screening Instruments Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Ultrasound Devices
Table 3. Major Players of Next-Generation Sequencing Systems
Table 4. Major Players of Polymerase Chain Reaction Instruments
Table 5. Major Players of Microarrays
Table 6. Major Players of Others
Table 7. Non-invasive Parenteral Screening Instruments Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 10. Non-invasive Parenteral Screening Instruments Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 13. Global Non-invasive Parenteral Screening Instruments Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Player (2019-2024)
Table 15. Non-invasive Parenteral Screening Instruments Key Players Head office and Products Offered
Table 16. Non-invasive Parenteral Screening Instruments Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Non-invasive Parenteral Screening Instruments Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Regions (2019-2024)
Table 21. Global Non-invasive Parenteral Screening Instruments Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Non-invasive Parenteral Screening Instruments Market Size Market Share by Country (2019-2024)
Table 25. Americas Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 27. Americas Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 29. APAC Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Region (2019-2024)
Table 31. APAC Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 33. APAC Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 35. Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Country (2019-2024)
Table 37. Europe Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 39. Europe Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Non-invasive Parenteral Screening Instruments
Table 48. Key Market Challenges & Risks of Non-invasive Parenteral Screening Instruments
Table 49. Key Industry Trends of Non-invasive Parenteral Screening Instruments
Table 50. Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Non-invasive Parenteral Screening Instruments Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. GE Healthcare Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 55. GE Healthcare Non-invasive Parenteral Screening Instruments Product Offered
Table 56. GE Healthcare Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. GE Healthcare Main Business
Table 58. GE Healthcare Latest Developments
Table 59. Philips Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 60. Philips Non-invasive Parenteral Screening Instruments Product Offered
Table 61. Philips Main Business
Table 62. Philips Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Philips Latest Developments
Table 64. Illumina Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 65. Illumina Non-invasive Parenteral Screening Instruments Product Offered
Table 66. Illumina Main Business
Table 67. Illumina Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Illumina Latest Developments
Table 69. Thermo Fisher Scientific Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 70. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product Offered
Table 71. Thermo Fisher Scientific Main Business
Table 72. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Thermo Fisher Scientific Latest Developments
Table 74. Roche Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 75. Roche Non-invasive Parenteral Screening Instruments Product Offered
Table 76. Roche Main Business
Table 77. Roche Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Roche Latest Developments
Table 79. PacBio Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 80. PacBio Non-invasive Parenteral Screening Instruments Product Offered
Table 81. PacBio Main Business
Table 82. PacBio Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. PacBio Latest Developments
Table 84. Perkinelmer Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 85. Perkinelmer Non-invasive Parenteral Screening Instruments Product Offered
Table 86. Perkinelmer Main Business
Table 87. Perkinelmer Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Perkinelmer Latest Developments
Table 89. Qiagen Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 90. Qiagen Non-invasive Parenteral Screening Instruments Product Offered
Table 91. Qiagen Main Business
Table 92. Qiagen Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Qiagen Latest Developments
Table 94. Agilent Technologies Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 95. Agilent Technologies Non-invasive Parenteral Screening Instruments Product Offered
Table 96. Agilent Technologies Main Business
Table 97. Agilent Technologies Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Agilent Technologies Latest Developments
Table 99. BGI Group Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 100. BGI Group Non-invasive Parenteral Screening Instruments Product Offered
Table 101. BGI Group Main Business
Table 102. BGI Group Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. BGI Group Latest Developments
Table 1. Non-invasive Parenteral Screening Instruments Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Ultrasound Devices
Table 3. Major Players of Next-Generation Sequencing Systems
Table 4. Major Players of Polymerase Chain Reaction Instruments
Table 5. Major Players of Microarrays
Table 6. Major Players of Others
Table 7. Non-invasive Parenteral Screening Instruments Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 10. Non-invasive Parenteral Screening Instruments Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 13. Global Non-invasive Parenteral Screening Instruments Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Player (2019-2024)
Table 15. Non-invasive Parenteral Screening Instruments Key Players Head office and Products Offered
Table 16. Non-invasive Parenteral Screening Instruments Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Non-invasive Parenteral Screening Instruments Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Regions (2019-2024)
Table 21. Global Non-invasive Parenteral Screening Instruments Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Non-invasive Parenteral Screening Instruments Market Size Market Share by Country (2019-2024)
Table 25. Americas Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 27. Americas Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 29. APAC Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Region (2019-2024)
Table 31. APAC Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 33. APAC Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 35. Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Country (2019-2024)
Table 37. Europe Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 39. Europe Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Non-invasive Parenteral Screening Instruments
Table 48. Key Market Challenges & Risks of Non-invasive Parenteral Screening Instruments
Table 49. Key Industry Trends of Non-invasive Parenteral Screening Instruments
Table 50. Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Non-invasive Parenteral Screening Instruments Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. GE Healthcare Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 55. GE Healthcare Non-invasive Parenteral Screening Instruments Product Offered
Table 56. GE Healthcare Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. GE Healthcare Main Business
Table 58. GE Healthcare Latest Developments
Table 59. Philips Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 60. Philips Non-invasive Parenteral Screening Instruments Product Offered
Table 61. Philips Main Business
Table 62. Philips Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Philips Latest Developments
Table 64. Illumina Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 65. Illumina Non-invasive Parenteral Screening Instruments Product Offered
Table 66. Illumina Main Business
Table 67. Illumina Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Illumina Latest Developments
Table 69. Thermo Fisher Scientific Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 70. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product Offered
Table 71. Thermo Fisher Scientific Main Business
Table 72. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Thermo Fisher Scientific Latest Developments
Table 74. Roche Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 75. Roche Non-invasive Parenteral Screening Instruments Product Offered
Table 76. Roche Main Business
Table 77. Roche Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Roche Latest Developments
Table 79. PacBio Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 80. PacBio Non-invasive Parenteral Screening Instruments Product Offered
Table 81. PacBio Main Business
Table 82. PacBio Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. PacBio Latest Developments
Table 84. Perkinelmer Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 85. Perkinelmer Non-invasive Parenteral Screening Instruments Product Offered
Table 86. Perkinelmer Main Business
Table 87. Perkinelmer Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Perkinelmer Latest Developments
Table 89. Qiagen Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 90. Qiagen Non-invasive Parenteral Screening Instruments Product Offered
Table 91. Qiagen Main Business
Table 92. Qiagen Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Qiagen Latest Developments
Table 94. Agilent Technologies Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 95. Agilent Technologies Non-invasive Parenteral Screening Instruments Product Offered
Table 96. Agilent Technologies Main Business
Table 97. Agilent Technologies Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Agilent Technologies Latest Developments
Table 99. BGI Group Details, Company Type, Non-invasive Parenteral Screening Instruments Area Served and Its Competitors
Table 100. BGI Group Non-invasive Parenteral Screening Instruments Product Offered
Table 101. BGI Group Main Business
Table 102. BGI Group Non-invasive Parenteral Screening Instruments Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. BGI Group Latest Developments
LIST OF FIGURES
Figure 1. Non-invasive Parenteral Screening Instruments Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Non-invasive Parenteral Screening Instruments Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Non-invasive Parenteral Screening Instruments Sales Market Share by Country/Region (2023)
Figure 8. Non-invasive Parenteral Screening Instruments Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Type in 2023
Figure 10. Non-invasive Parenteral Screening Instruments in Diagnostic Laboratories
Figure 11. Global Non-invasive Parenteral Screening Instruments Market: Diagnostic Laboratories (2019-2024) & ($ Millions)
Figure 12. Non-invasive Parenteral Screening Instruments in Hospitals
Figure 13. Global Non-invasive Parenteral Screening Instruments Market: Hospitals (2019-2024) & ($ Millions)
Figure 14. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Application in 2023
Figure 15. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Player in 2023
Figure 16. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Non-invasive Parenteral Screening Instruments Market Size 2019-2024 ($ Millions)
Figure 18. APAC Non-invasive Parenteral Screening Instruments Market Size 2019-2024 ($ Millions)
Figure 19. Europe Non-invasive Parenteral Screening Instruments Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size 2019-2024 ($ Millions)
Figure 21. Americas Non-invasive Parenteral Screening Instruments Value Market Share by Country in 2023
Figure 22. United States Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Region in 2023
Figure 27. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Type in 2023
Figure 28. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Application in 2023
Figure 29. China Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Country in 2023
Figure 36. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Figure 37. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Figure 38. Germany Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 52. APAC Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 53. Europe Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 55. United States Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 56. Canada Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 59. China Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 60. Japan Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 61. Korea Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 63. India Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 64. Australia Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 65. Germany Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 66. France Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 67. UK Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 68. Italy Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 69. Russia Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 70. Spain Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 73. Israel Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 76. Global Non-invasive Parenteral Screening Instruments Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Non-invasive Parenteral Screening Instruments Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Non-invasive Parenteral Screening Instruments Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Non-invasive Parenteral Screening Instruments Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Non-invasive Parenteral Screening Instruments Sales Market Share by Country/Region (2023)
Figure 8. Non-invasive Parenteral Screening Instruments Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Type in 2023
Figure 10. Non-invasive Parenteral Screening Instruments in Diagnostic Laboratories
Figure 11. Global Non-invasive Parenteral Screening Instruments Market: Diagnostic Laboratories (2019-2024) & ($ Millions)
Figure 12. Non-invasive Parenteral Screening Instruments in Hospitals
Figure 13. Global Non-invasive Parenteral Screening Instruments Market: Hospitals (2019-2024) & ($ Millions)
Figure 14. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Application in 2023
Figure 15. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Player in 2023
Figure 16. Global Non-invasive Parenteral Screening Instruments Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Non-invasive Parenteral Screening Instruments Market Size 2019-2024 ($ Millions)
Figure 18. APAC Non-invasive Parenteral Screening Instruments Market Size 2019-2024 ($ Millions)
Figure 19. Europe Non-invasive Parenteral Screening Instruments Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size 2019-2024 ($ Millions)
Figure 21. Americas Non-invasive Parenteral Screening Instruments Value Market Share by Country in 2023
Figure 22. United States Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Region in 2023
Figure 27. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Type in 2023
Figure 28. APAC Non-invasive Parenteral Screening Instruments Market Size Market Share by Application in 2023
Figure 29. China Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Country in 2023
Figure 36. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Figure 37. Europe Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Figure 38. Germany Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Non-invasive Parenteral Screening Instruments Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 52. APAC Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 53. Europe Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 55. United States Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 56. Canada Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 59. China Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 60. Japan Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 61. Korea Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 63. India Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 64. Australia Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 65. Germany Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 66. France Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 67. UK Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 68. Italy Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 69. Russia Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 70. Spain Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 73. Israel Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Non-invasive Parenteral Screening Instruments Market Size 2025-2030 ($ Millions)
Figure 76. Global Non-invasive Parenteral Screening Instruments Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Non-invasive Parenteral Screening Instruments Market Size Market Share Forecast by Application (2025-2030)
